The effects of elastase on lipid metabolism, platelet function, and blood coagulability were evaluated in 18 patients with diabetes mellitus. Blood sampling was made before medication, and after oral administration of 10800 units of elastase per day 8 and 16 weeks. Measurements were made for platelet counts, platelet sensitivity to ADP-aggregation, serum concentrations of total cholesterol HDLcholesterol triglyceride and plasma concentrations of B-thromboglobulin (S-TG) fibrinogen (Fbg) antithrombin III (AT III).
After p<0.05). In conclusion, elastase improved lipid metabolism, suppressed platelet release reaction and increased AT III level. Therefore, it is suggested that elastase will be one of the useful drugs for protection of vascular complications in diabetes mellitus. 
